Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Neomend, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Neomend, Inc.

Regulatory records
4
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Neomend, Inc.. 4 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 18, 2025 to Mar 12, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code NBE appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P010047, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 60 Technology Dr., Irvine, CA, 92618. Recorded on P010047/S073, decision dated Mar 12, 2026.

Changes described in PMA records

P010047/S073: PROGEL Pleural Air Leak Sealant

FDA’s recorded scope: For the reduction of testing frequency for Air Flow Test, Standard Spray Tips and Extended Spray Tips; removal of Neomend Inc. Pouch Peel Strength Testing for Incoming Packaging Materials with the adoption of Supplier-Performed ASTM F88 Testing for Chevron Seal Pouches; and elimination of SDS-PAGE Lot Release Testing

Mar 12, 2026 · 30-Day Notice

P150016/S028: TRIDYNE Vascular Sealant

FDA’s recorded scope: For the reduction of testing frequency for Air Flow Test, Standard Spray Tips and Extended Spray Tips; removal of Neomend Inc. Pouch Peel Strength Testing for Incoming Packaging Materials with the adoption of Supplier-Performed ASTM F88 Testing for Chevron Seal Pouches; and elimination of SDS-PAGE Lot Release Testing

Mar 12, 2026 · 30-Day Notice

P150016/S027: TRIDYNE Vascular Sealant

FDA’s recorded scope: to reduce the testing frequencies of three tests for the TRIDYNE Vascular Sealant and the PROGEL Pleural Air Leak Sealant

Dec 18, 2025 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Neomend, Inc.PMA supplementMar 12, 2026FDA
Neomend, Inc.PMA supplementMar 12, 2026FDA
Neomend, Inc.PMA supplementDec 18, 2025FDA
Neomend, Inc.PMA supplementDec 18, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.